Davidson Trust Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $576K | Sell |
12,436
-1,628
| -12% | -$75.4K | 0.27% | 90 |
|
2025
Q1 | $858K | Buy |
14,064
+1,285
| +10% | +$78.4K | 0.41% | 62 |
|
2024
Q4 | $723K | Buy |
12,779
+222
| +2% | +$12.6K | 0.37% | 65 |
|
2024
Q3 | $650K | Buy |
12,557
+203
| +2% | +$10.5K | 0.33% | 72 |
|
2024
Q2 | $513K | Buy |
12,354
+829
| +7% | +$34.4K | 0.35% | 78 |
|
2024
Q1 | $625K | Buy |
11,525
+563
| +5% | +$30.5K | 0.36% | 73 |
|
2023
Q4 | $562K | Buy |
10,962
+204
| +2% | +$10.5K | 0.36% | 71 |
|
2023
Q3 | $624K | Buy |
10,758
+137
| +1% | +$7.95K | 0.46% | 54 |
|
2023
Q2 | $679K | Hold |
10,621
| – | – | 0.49% | 53 |
|
2023
Q1 | $736K | Buy |
10,621
+2,090
| +24% | +$145K | 0.57% | 47 |
|
2022
Q4 | $614K | Hold |
8,531
| – | – | 0.54% | 49 |
|
2022
Q3 | $606K | Sell |
8,531
-65
| -0.8% | -$4.62K | 0.58% | 48 |
|
2022
Q2 | $662K | Sell |
8,596
-320
| -4% | -$24.6K | 0.59% | 49 |
|
2022
Q1 | $651K | Sell |
8,916
-360
| -4% | -$26.3K | 0.48% | 58 |
|
2021
Q4 | $578K | Buy |
9,276
+331
| +4% | +$20.6K | 0.4% | 67 |
|
2021
Q3 | $529K | Buy |
8,945
+275
| +3% | +$16.3K | 0.4% | 66 |
|
2021
Q2 | $579K | Sell |
8,670
-717
| -8% | -$47.9K | 0.45% | 63 |
|
2021
Q1 | $592K | Buy |
9,387
+60
| +0.6% | +$3.78K | 0.5% | 59 |
|
2020
Q4 | $577K | Hold |
9,327
| – | – | 0.5% | 58 |
|
2020
Q3 | $561K | Sell |
9,327
-70
| -0.7% | -$4.21K | 0.51% | 57 |
|
2020
Q2 | $552K | Hold |
9,397
| – | – | 0.54% | 55 |
|
2020
Q1 | $523K | Buy |
9,397
+607
| +7% | +$33.8K | 0.65% | 47 |
|
2019
Q4 | $564K | Buy |
+8,790
| New | +$564K | 0.57% | 50 |
|